*Toxoplasma gondii*, an obligate intracellular protozoan parasite, infects close to a billion people worldwide ([@b136-co-2-837]) and is an important agent of animal and human disease worldwide ([@b35-co-2-837]; [@b145-co-2-837]; [@b104-co-2-837]).

Toxoplasmosis in humans and other mammals is acquired by oral ingestion of either tissue cysts in raw or undercooked meat from chronically infected intermediate hosts or by ingestion of oocysts shed by cats by way of fecal contamination of food or water ([@b41-co-2-837], [@b42-co-2-837]). Once ingested, the cyst wall is digested within the lumen of the small intestine. The acute phase of infection is characterized by wide-spread dissemination of rapidly dividing tachyzoites that invade virtually all cell types.

During the inflammatory process, soluble mediators and cellular components work together in a systematic manner in the attempt to contain and to eliminate the agents causing physical distress. The nature and portal of entry of the foreign substance and, to some degree, the nature and circumstances of a particular individual influence the way in which the inflammatory process is initiated.

Pathogens can initiate inflammation by a number of distinct and characteristic mechanisms, including activation of the plasma protease systems by interaction with degradation products of the pathogens and by secretion of toxins that can activate the inflammatory response directly. Injured cells themselves can release degradation products that initiate one or more of the plasma protease cascades and augment expression of proinflammatory cytokines that promote the inflammatory process. The physiological changes in inflammation are crucial to maintain the health and integrity of an organism, however, the inflammatory process can result in massive tissue destruction when poorly controlled.

During invasion of *T. gondii*, the host cell is essentially passive and no change is detected in membrane ruffling, actin cytoskeleton, or phosphorylation of host cell proteins ([@b44-co-2-837]; [@b88-co-2-837]; [@b101-co-2-837]; [@b70-co-2-837]). The invasion is an active parasite-mediated process, initiated by contact between the apex of *T. gondii* and the host cell surface, involving many host receptors (proteoglycans like heparin and heparin-sulphate, β-integrins) and parasite ligands such as surface antigens (SAG), surface antigen-related sequences (SRS), microneme proteins (MIC), and laminin ([@b148-co-2-837]).

Intestinal epithelial cells probably are the first cells infected by *T. gondii*. Chemokines released by these cells play a critical role in the initiation and modulation of immune response to various pathogens ([@b103-co-2-837]). They are responsible for the chemoattraction of polymorphonuclear neutrophils (PMNs), dendritic cells (DC), macrophages (MØ), and lymphocytes ([@b86-co-2-837]). *T. gondii* infects and can be disseminated by these cells to other organs throughout the host, especially to, muscle and central nervous system.

The disease in animal models
============================

The *T. gondii* mouse infection model, because of its simplicity and robust responses it generates, has proven a powerful tool for studying host-microbe interactions. Because of that, most of the data published on immune responses and genes implicated in susceptibility derive from studies employing inbred mouse strains. Infection of mice leads to lifelong persistence of the parasite. Outcome is variable, depending on the interaction of many factors like inoculum size ([@b81-co-2-837]), virulence of the organism ([@b125-co-2-837]), life cycle stage of the parasite ([@b71-co-2-837]; [@b91-co-2-837]; [@b127-co-2-837], [@b130-co-2-837]), genetic background ([@b143-co-2-837]; [@b92-co-2-837]; [@b131-co-2-837]; [@b83-co-2-837]), gender ([@b107-co-2-837]), and immunological status. All these factors seem to affect the course of infection in human beings and in animal models of toxoplasmosis.

Murine susceptibility to *T. gondii* or resistance to mortality following acute oral infection is under multigenic control by the host ([@b143-co-2-837]; [@b91-co-2-837]; [@b72-co-2-837]). In C57BL/6 mice, genes both within and outside of the major histocompatibility complex (MHC) are involved in impaired intracerebral immune response ([@b18-co-2-837]; [@b30-co-2-837]).

The ability of mice to survive *T. gondii* infection is dependent on strong T cell-mediated immunity. Both CD4+ T helper (Th) 1 cells and CD8+ cytolytic T lymphocytes are vital in providing protective immunity and long-term survival during chronic infection, as determined by *in vivo* depletion studies and adoptive transfer of CD4+ and CD8+ T cell lines and clones ([@b129-co-2-837]; [@b48-co-2-837], [@b46-co-2-837]; [@b102-co-2-837]; [@b74-co-2-837]; [@b19-co-2-837]). If the host becomes immunosuppressed, chronic infection can be reactivated, leading to toxoplasmic encephalitis, which is often fatal if not treated ([@b126-co-2-837]).

The protective competence of these cell types is due to their ability to produce interferon (IFN)-γ, a pro-inflammatory cytokine that has become well known as the major mediator of resistance to *T. gondii* ([@b129-co-2-837]). Mice that do not express IFN-γ (IFN-γ knockout mice) are unable to survive the acute phase of infection ([@b111-co-2-837]). Antibody-mediated depletion of this cytokine during chronic infection demonstrates that continued IFN-γ production is necessary for long-term survival ([@b46-co-2-837]). However, pathologic consequences due to overproduction of cytokines and excessive activation of the immune system are observed in IL-10 knockout (IL-10 KO) mice infected with *T. gondii* ([@b52-co-2-837]) or wild type mice infected with highly virulent strains ([@b97-co-2-837]).

The activation of murine macrophages (MØ) by IFN-γ in the presence of additional signals, such as lipopolysaccharide (LPS) or tumor necrosis factor-α (TNF-α), is necessary to trigger the cytotoxic activity of MØ against *T. gondii* ([@b116-co-2-837]). IFN-γ exerts its antimicrobial activity through induction of specific effector molecules, including reactive nitrogen intermediates that interfere with key metabolic enzymes ([@b76-co-2-837]; [@b112-co-2-837]; [@b108-co-2-837]), indoleamine 2,3-dioxygenase (IDO) that induces tryptophan degradation thereby interfering with viability of the parasite ([@b87-co-2-837]; [@b43-co-2-837]; [@b117-co-2-837]), and a family of GTP-binding proteins. IFN-γ-inducible GTP-binding proteins IGTP and LRP-47 are required for the mice to survive acute *T. gondii* infection, while nitric oxide-dependent protection may be more important during chronic infection ([@b134-co-2-837]; [@b23-co-2-837]).

The intraocular inflammatory response to the parasite is also mediated primarily by the CD4^+^ T- and CD8+ T-cell responses. CD8^+^ T cells recognize and destroy parasite-infected cells in an MHC class I restricted manner. However, as part of the local immune privilege, cells in the eye express low levels of MHC class I while infected mice usually show increased expression ([@b85-co-2-837]). This would, in turn, permit the precise targeting of *T. gondii*-infected cells by CD8+ cytolytic T lymphocytes and unlike other killing mechanisms that rely on soluble mediators, would limit collateral damage to uninfected cells. Indeed, depletion of the CD8^+^ cell subset resulted in increased lesion formation and cyst burden in an acquired disease model of infection ([@b47-co-2-837]), and a severe necrosis accompanied by higher ocular parasite burdens, in CD8-deficient mice immunized and challenged by a intraocular inoculum ([@b84-co-2-837]). B cells may also contribute by limiting tachyzoite proliferation in the eyes ([@b84-co-2-837]).

Programmed cell death is an important protective strategy used in immune-privileged organs. Fas is expressed on a variety of immune and nonimmune cells, whilst FasL is evident on T cells as well as in immune-privileged tissues. Ligation of these two surface molecules results in apoptosis of the Fas-expressing cell. In this way, the eye can prevent the damage caused by infiltrating lymphocytes and activated T cells can induce apoptosis in infected cells. *T. gondii* induces increased Fas and FasL expression on the cells of mouse retina. When intracamerally inoculated with tachyzoites of one virulent strain, Fas- and FasL-defective mice exhibit greater inflammatory scores and a more severe histopathology than similarly infected wild-type mice, added to a reduced ability to limit parasite proliferation early in infection ([@b66-co-2-837], [@b67-co-2-837]). However, when intraperitoneally inoculated with a less virulent strain, the same mice showed no difference in the degree of ocular inflammation and apoptosis. The higher level of IFN-γ and NO apparent early in these mice must have provided an alternative means to control parasitemia in the absence of Fas or FasL expression ([@b115-co-2-837]).

In the immunosuppressed environment of the eye with high levels of TGF-β antigen-presenting cells can produce IL-10 when activated, which would stimulate the expansion of a regulatory T cell subset able to counteract the Th1 type pro-inflammatory responses and thus maintain the immune privilege. Nevertheless, the ocular pathogenesis in C57BL/6 mice is more severe than that of BALB/c and CBA/J mice and the serum levels of IFN-γ and TNF-α in C57BL/6 mice are significantly higher than those in BALB/c and CBA/J mice following ocular infection with a virulent strain of *T. gondii* ([@b83-co-2-837]). There are higher levels of IFN-γ mRNA expression in the retinas of C57BL/6 mice than in those of BALB/c mice infected with *T. gondii* ([@b99-co-2-837]). Furthermore, a decline in IFN-γ production in CD4-KO mice protects mice from mortality due to an exacerbated immune response ([@b21-co-2-837]). IFN-γ has been shown to regulate the *T. gondii* load and inter-conversion between the bradyzoite and tachyzoite stages of *T. gondii* in the murine eye ([@b99-co-2-837]). Therefore, IFN-γ mediates immunopathology and contributes to early death following *T. gondii* infection ([@b82-co-2-837]).

Toxoplasmosis
=============

Some recent studies support the idea that *T. gondii* is a master manipulator of host immune responses. The parasite simultaneously triggers the secretion of protective cytokines (IFN-γ and IL-12) and paradoxically suppresses the same type of response ([@b32-co-2-837]; [@b45-co-2-837]). This dual capacity of the parasite could actually be beneficial and allow the establishment of a stable host--parasite interaction. Failure to successfully synchronize these responses has negative consequences for both. Antimicrobial protection is ensured by the coordinated action of the innate and adaptative immune systems. Molecular communication between the host innate immune system and the intracellular protozoan *T. gondii* is fast emerging as a dramatic example of these key principles in action.

In the immunocompetent host the acute infection is usually asymptomatic or causes a influenza-like syndrome, and rarely leads to severe symptoms such as interstitial pneumonia, pericardial effusions, myositis, myocarditis, and neurological disorders (retinochoroiditis, Guillain-Barré syndrome, mental confusion) ([@b15-co-2-837]). Encephalitis is most commonly seen in immunocompromised individuals whereas uveitis is the most common lesion appearing in immunocompetent individuals ([@b60-co-2-837]). The infection incites a quasiefficient immune response, which controls parasitemia but allows tissue cysts to form in the brain, eyes, and muscles, leading to lifelong persistence of the parasite and variable medical outcome.

Dissemination of *T. gondii* in immunocompromised hosts, such as AIDS patients with very low CD4 counts, patients under immunosuppression to prevent or treat transplant rejection, and fetuses, is common, and often represents a reactivation of an earlier infection, rather than a newly acquired one. In these individuals the parasite can, besides encephalitis and retinochoroiditis, cause carditis, pneumonia, and meningitis, amongst other manifestations ([@b60-co-2-837]; [@b93-co-2-837]; [@b94-co-2-837]).

Ocular lesions may result from congenital or after birth-acquired infections. The lesion is often necrotic, destroying the architecture of the neural retina and sometimes involving the choroid (retinochoroiditis). Typical findings of toxoplasmic retinochoroiditis include white focal lesions with an intense overlaying and vitreal inflammatory reaction. Toxoplasmic retinochoroiditis is the most common lesion caused by infection with this protozoan and it may occur either immediately or long after the initial infection ([@b119-co-2-837]; [@b24-co-2-837]; [@b95-co-2-837]) or reactivation ([@b14-co-2-837]).

Recurrent lesions are usually identified at the borders of the retinochoroidal scars, are typically found in clusters, and have been attributed to the rupture of tissue cysts within these old lesions or eventually coming from other tissues due to activation of memory immune cells. It is thought that the satellite lesions occurring both in the brain and the eye are caused by rupture of local cysts ([@b62-co-2-837], [@b63-co-2-837]), but the origin of active infections in remote tissues has been credited to either clinically unapparent tissue cysts or to re-infection ([@b60-co-2-837]). In this last case, it is conceivable that the immune response by memory cells might be triggered by circulating parasites or even by other infections, through the activation of IFN-γ and other inflammatory mediators.

Many questions about the disease still remain that confound ophthalmologists ([@b141-co-2-837]; [@b62-co-2-837], [@b63-co-2-837]). The response to antibiotic therapy alone or in combination with corticosteroids varies widely among patients ([@b122-co-2-837]). Clinical presentation also varies, with some patients presenting only one episode of mild inflammation whereas others have multiple recurrences of severe uveitis leading to loss of eyesight. The immune response against retinal antigens does not explain the extensive damage to the eye in patients with ocular toxoplasmosis. Furthermore, we have presented data suggesting that a controlled autoimmune response may develop after infection with *T. gondii* in some patients and, in addition, may help to prevent the parasite from spreading through the retina thus associated with a milder disease ([@b139-co-2-837]).

Familial ocular toxoplasmosis is found in southern Brazil, where the incidence of ocular toxoplasmosis is higher than in most regions of the globe, and accounts for 70% to 90% of all uveitis cases seen in rural areas. A household survey in the endemic area showed 17,7% (186/1,042) of the population had toxoplasmic scars in the retina ([@b119-co-2-837]; [@b54-co-2-837]), a finding that cannot be explained by congenital infection alone ([@b62-co-2-837], [@b63-co-2-837]). The same population was reassessed 7 and 11 years later and showed that seroconversion was more frequent in individuals under 17 years of age or above 50 years of age, with a risk of 10% of ocular involvement ([@b120-co-2-837]; [@b118-co-2-837]). Finally, acquired infection causing late necrotizing retinochoroiditis is seen not only in Brazil ([@b100-co-2-837]), but also in Europe ([@b17-co-2-837]) and in the USA ([@b95-co-2-837]).

Analysis of systemic cellular response to *T. gondii* antigen in 136 subjects with a diagnosis of ocular toxoplasmosis, no ocular disease or no infection by *T. gondii* suggested that resistance to the development of ocular toxoplasmosis has been associated with the ability to mount a lasting T-helper (Th) 1-type response (IL-2 and IFN-γ production) to the parasite antigens. On the other hand, susceptibility has also been associated with an inflammatory response, mostly mediated by cytokines (IL-1 and TNF-α) possibly produced by activated macrophages (MØ), which may themselves take part in the pathological features of the disease ([@b146-co-2-837]).

A recent study performed in France is in opposition to our study. Analyzing the induction of CD25 expression, no significant difference was observed in immune response among 16 individuals with a diagnosis of congenital, acquired, or undetermined ocular toxoplasmosis or between patients with active or inactive ocular lesions. Furthermore, higher levels of IFN-γ were detected in stimulated blood cultures from infected patients than in those from controls, with no difference between patients with asymptomatic or ocular toxoplasmosis ([@b40-co-2-837]).

TNF-α also plays an important role in murine resistance to acute and chronic toxoplasmosis ([@b22-co-2-837]; [@b73-co-2-837]; [@b78-co-2-837]). However, high levels of this cytokine produced during any lethal infection can potentially contribute to harmful cerebral and hepatic effects ([@b8-co-2-837]; [@b6-co-2-837]; [@b89-co-2-837]). Furthermore, TNF-α may aid the intracerebral dissemination of *T. gondii* in mice ([@b56-co-2-837]) and may be increased in toxoplasmic retinochoroidal in humans ([@b146-co-2-837]).

We have shown that individuals with ocular toxoplasmosis from congenital infection have a diminished immune response towards *T. gondii* antigens when compared with individuals with ocular disease due to acquired infection ([@b146-co-2-837]). Interestingly, unlike mice, the diminished response is not caused by a superantigen ([@b142-co-2-837]). This means that, despite the similarity at macroscopic and histopathologic level, the lesions seen on ocular toxoplasmosis may be generated by different mechanisms, therefore explaining the wide range of responses to available therapy.

Toxoplasma genotype and pathology
---------------------------------

Variation of clinical presentation and severity of disease in susceptible individuals has been attributed to several factors, including host genetic heterogeneity and parasite genotype ([@b13-co-2-837]). We have typed *T. gondii* strains in Brazil ([@b140-co-2-837]) and our findings reveal that the highly clonal population structure of *T. gondii* seen in North America and Europe does not predominate in South America ([@b75-co-2-837]). Identification of the direct players in host--pathogen interactions during the initial infection and chronic phases of the disease is perhaps the best hope for better clinical treatment in this region.

Population studies analyzing more than 50 different genetic markers have identified a limited number of *T. gondii* genotypes in nature, despite the presence of a sexual phase in the life cycle, a wide geographical distribution and a broad range of intermediate hosts. Phylogenetic analysis detects 2 main groups in *T. gondii* population. From a practical point of view, 3 main lineages (type I, type II, and type III) that despite sharing about 98% genetic identity differ in virulence and epidemiological pattern of occurrence ([@b26-co-2-837]; [@b132-co-2-837]), are usually considered. For most groups, allelic polymorphism is low (2 to 4 alleles) ([@b27-co-2-837]; [@b65-co-2-837]; [@b2-co-2-837]), indicating that they descend recently from two closely-related parents that underwent a small number of genetic recombination events. Less than 1% of the previously studied strains contain unique genotypes and high divergence of DNA sequence, and have therefore been considered 'exotic' or 'atypical' strains ([@b124-co-2-837]). However, it was demonstrated that sexual recombination combining polymorphisms in two of these distinct and competing clonal lines, can be a powerful force driving the natural evolution of virulence in this highly successful pathogen ([@b57-co-2-837]).

The apparently low genetic diversity in *T. gondii* may have been underestimated because most parasite strains in previous studies were collected from human patients and domestic animals in North America and Europe. The choice largely employed by researchers is using the *SAG2* locus for rapid typing since it is capable of distinguishing all three alleles from a single locus ([@b64-co-2-837]). This method is also widely used in other genes where the population structure has not been studied so extensively, therefore genetic diversity is under-represented. Several studies have examined the distribution of genotypes in chickens from countries such as Egypt, Argentina, India, and Brazil ([@b36-co-2-837], [@b37-co-2-837], [@b38-co-2-837], [@b39-co-2-837]; [@b121-co-2-837]; [@b79-co-2-837]), but the genetic studies were limited by the use of only one marker (*SAG2*) (except \[[@b121-co-2-837]; [@b79-co-2-837]\]), and because chickens in farms are indicators of strain prevalence in a domestic or peridomestic environment. Strains isolated from humans and animals (rabbit, mouse, goat, chickens, and dogs) in Minas Gerais, Brazil were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR--RFLP) at eight independent loci and all strains carried recombinant genotypes, with typical types I, II, or III in almost all loci assessed ([@b29-co-2-837]).

We also have identified type I *T. gondii* strains by PCR-based typing at the *SAG2* locus in retinochoroidal specimens from Brazil ([@b140-co-2-837]). When analyzed by multilocus PCR-RFLP, our recent findings reveal that the highly clonal population structure of *T. gondii* seen in North America and Europe does not predominate in South America ([@b75-co-2-837]). Consistent with this observation, *T. gondii* strains isolated from French Guiana patients are also highly diversified and not characteristic of a clonal organism as seen in North America strains ([@b1-co-2-837]).

In the Brazilian strains, genotyping showed no cases of mixed infection (two alleles at a given locus). Unfortunately, the true extent of sequence divergence is not captured by multilocus RFLP and microsatellite analysis tends to overestimate genetic divergence. The *UPRT*-1 intron sequence was compared, and all except one strain from Brazil proved to have multiple additional polymorphisms not seen in the clonal lineages. This analysis suggested the presence of more than one predominant haplotype in Brazil along with less common unique genotypes ([@b75-co-2-837]).

It has been suggested previously that such divergent strains are more ancient in origin than the recently derived clonal lineages and that *T. gondii* expansion is linked to enhanced oral transmission between intermediate hosts, a trait not shared by other closely related parasites ([@b124-co-2-837]). Despite of high serologic prevalence and level of recurrent ocular disease in Erechim, Brazil ([@b54-co-2-837]), it is premature to say that sexual reproduction plays a central role in the population structure of *T. gondii*, since there were no cases of mixed infection. Given that the samples are from two small outbreaks and one of them due to food borne. It is likewise early to describe the epidemiology of toxoplasmosis in Brazil, since it is a country of continential size, boasting tropical and subtropical areas.

Recent studies in mice have identified some genes responsible for the strain-specific differences in virulence ([@b135-co-2-837]; [@b109-co-2-837]), where type I strains are more virulent than types II and III. As virulence is a multigenic trait, crossing the less virulent type II and type III strains generates some F1 progeny in which the virulence is greatly enhanced. The use of QTL mapping in such progeny identified a total of five virulence loci, including one on chromosome VIIa, which was found to correspond to *ROP18*, and one on chromosome VIIb, which corresponded to a gene encoding another rhoptry kinase, ROP16 ([@b109-co-2-837]). *ROP18* encodes the ROP18 protein, which is a functional serine kinase and is secreted into host cells ([@b135-co-2-837]). ROP16 is a key modulator of the host response and the three clonal lineages differ in their level of activation of the STAT signaling pathway. As this is the pathway to the crucial cytokine interleukin 12, ROP16 is involved in this effect ([@b109-co-2-837]). It seems that these eukaryotic pathogens can secrete protein kinases into host cells to subvert host-cell signaling pathways and that this explains many of the differences in virulence among the three dominant clonal lineages.

Our findings reveal that the genetic makeup of *T. gondii* is more complex than previously recognized and are in agreement that unique or divergent genotypes may contribute to different clinical outcomes of toxoplasmosis in different localities. Further strain comparisons based on a wider set of sequence based markers will be necessary to define the global population structure of *T. gondii* and to resolve the relationships between major strain types seen in different geographic regions.

Host genotype and the immune response to *T. gondii*
====================================================

A wide array of studies has further demonstrated differences in genotype and allele frequencies of cytokine gene polymorphisms depending on ethnicity and race ([@b55-co-2-837]; [@b25-co-2-837]; [@b138-co-2-837]). Cytokines and chemokines and Toll-like receptors play a key role in the regulation of the type and magnitude of immune response, and the polymorphic nature of these genes may confer further flexibility to the immune response ([@b113-co-2-837]). We have analyzed some of the genes involved in the response against *T. gondii* infection, whose functions are detailed in the following pages.

Toll-like receptors
-------------------

Toll-like receptors (TLRs) have been recently defined as important transmembrane proteins that can confer a certain degree of specificity to the cells of the innate immune compartment. TLRs, also referred to as pattern recognition receptors (PRRs), have been implicated in recognition of every known category of pathogen that causes human disease and whose signaling through the common adaptor molecule myeloid differentiation primary-response protein 88 (MyD88) is essential in proinflammatory cytokine responses to many microbial pathogens.

TLRs can recognize traces of microbial components and orchestrate an early defense, largely dependent on the activation of nuclear factor-kappaB (NF-κB), which will lead to the production of proinflammatory cytokines and triggering of microbiostatic/microbicidal effector mechanisms ([@b69-co-2-837]). While major advances have been made in the assignment of individual TLRs to defined roles in bacterial infections ([@b133-co-2-837]), such identification has only recently begun to emerge in protozoan parasites ([@b50-co-2-837]).

Mice that are deficient in the TLR adaptor protein MyD88 were found to have a pronounced decrease in IL-12 production by peritoneal macrophages, neutrophils, and splenic DC in response to soluble tachyzoite antigen (STAg) stimulation *in vivo* and *in vitro* being highly susceptible to the acute infection with low doses of the infective stage of *T. gondii* ([@b110-co-2-837]). At this lower parasite dose, neither TLR2 nor TLR4 were important for mouse resistance to infection with *T. gondii*. In addition, DC from TLR2- or TLR4-KO mice developed normal IL-12 responses to STAg ([@b110-co-2-837]) just as PMNs from TLR2-KO animals did ([@b31-co-2-837]). TLR2-KO mice produce sufficient IL-12 to mediate partial protection that is nonetheless not enough to provide complete resistance to high dose infection, as compared to the wild type or TLR4-KO mice ([@b98-co-2-837]). Hence, TLR2 might be involved in the early activation of the innate immune system during infection with *T. gondii* to be partially involved in the parasite recognition and MyD88 activation during early stages of infection with *T. gondii.* It seems that the defect seen in TLR2-KO mice is due to inefficient activation of microbicidal functions, with diminished nitric-oxide production by macrophages ([@b98-co-2-837]).

Alternatively, MyD88-dependent neutrophil production of CCL2 (monocyte chemoattractant protein 1), but not IL-12, is dependent upon TLR2 signaling and defective CCL2 release could confer partial susceptibility to infection ([@b31-co-2-837]). Of note, neutrophil IL-12 production is not dependent upon parasite cyclophilin-18 (C-18), a *T. gondii* protein shown to trigger DC IL-12 through CCR5 ligation ([@b4-co-2-837]). Thus, *T. gondii* possesses multiple molecules triggering distinct MyD88-dependent signaling cascades, and as these pathways are independently regulated, they may lead to distinct profiles of cytokine production ([@b31-co-2-837]).

MyD88 signaling occurs also through IL-1R or IL-18R, but ICE-KO mice (lacking functional IL-1 and IL-18) exhibit no increased susceptibility to infection suggesting that signaling through IL-1R and IL-18R is not essential for responses against *T. gondii* infection. Importantly, TLR1-, TLR2-, TLR4-, TLR6-, and TLR9-KO mice exhibited similar resistance to infection compared with wild-type mice suggesting that these receptors are not independently essential for control of *T. gondii* infection ([@b61-co-2-837]).

A recent study from our laboratory indicates that there is no association between polymorphisms in TLR2 (Arg677Trp and Arg763Gln) and TLR4 (Asp299Gly) and ocular toxoplasmosis in Brazilian patients (unpublished observations), a finding in keeping with the observations in the murine model.

On the other hand, of the whole family of TLRs, two distinct TLR have been implicated in the recognition of protein ligands. TLR5 has been shown to be triggered by bacterial flagellin while TLR11 signaling is stimulated by protease sensitive molecules in uropathogenic bacteria ([@b59-co-2-837]; [@b150-co-2-837]). TLR11 was implicated in resistance to *T. gondii* when an additional ligand in the parasite, *T. gondii* profilin (PTG), that apparently triggers high DC IL-12 production by a MyD88 dependent but CCR5 independent pathway, was discovered ([@b149-co-2-837]). Interestingly, while DC IL-12 production appeared to be almost totally impaired in TLR11-KO mice infected with *T. gondii*, these animals, unlike either MyD88 or IL-12-KO mice ([@b105-co-2-837]) retained partial resistance to challenge and survived the acute phase of the infection, most likely due to a residual IFN-γ response ([@b149-co-2-837]). It is important to note however, that human TLR11 is nonfunctional because of the presence of a stop codon in the gene ([@b150-co-2-837]). At present it is not clear whether TLR11 recognition of *T. gondii* is of importance in limiting infection in other mammalian species or whether humans utilize alternative pattern recognition receptors in the innate response to *T. gondii*.

Interleukin-12
--------------

Immunity to *T. gondii* involves acute inflammatory responses and antigen-specific adaptive immunity ([@b34-co-2-837]; [@b20-co-2-837]). Central to host resistance is the generation of IFN-γ by innate-type natural killer (NK) cells and adaptive CD4 and CD8 T lymphocytes ([@b129-co-2-837], [@b128-co-2-837]). IL-12 has been identified as critical for driving prompt IFN-γ production and proper differentiation of Th1 lymphocytes during the immune response to *T. gondii* ([@b51-co-2-837]; [@b147-co-2-837]).

IL-12 is produced by PMNs, DC, B cells and other antigen-presenting cells (APCs). PMNs store cytokines in pre-formed pools namely IL-12, IL-6, MIP-2 in mouse neutrophils in the absence of infection ([@b137-co-2-837]; [@b10-co-2-837]; [@b90-co-2-837]), and IL-4 in PMN from healthy human donors ([@b16-co-2-837]). *T. gondii* induces secretion of IL-12 directly and rapidly by both human and mouse neutrophils, DCs as well as MØ ([@b49-co-2-837]; [@b105-co-2-837]; [@b11-co-2-837], [@b12-co-2-837]; [@b33-co-2-837]; [@b106-co-2-837]). Release of IL-12 does not require IFN-γ priming since responses are intact in gene-targeted mice lacking this cytokine. On the other hand, recombinant TNF-α alone stimulates CCL2 and CCL4 production by PMN, and therefore, the ability of *T. gondii* to trigger TNF-α may provide an important positive feedback loop for release of neutrophil CCL2 and CCL4, important chemokines which recruit macrophages and other cells to infected tissue. *T. gondii* also induces up regulation of RANTES (CCL5), MIP-3α (CCL20) and macrophage chemoattractant protein-1 (MCP-1; CCL2) gene transcription by PMN ([@b7-co-2-837]), which recruited to the site of infection by chemokines such as IL-8 and MCP-1, are themselves equipped to immediately release cytokines and chemokines that contribute further to cell recruitment and activation.

IL-12 is composed of two subunits, IL-12 p40 and IL-12 p35. In the absence of the IL-12 p40 gene or the IL-12-receptor-associated signal transducers Tyk2 and STAT-4, IFN-γ production is severely impaired resulting in enhanced susceptibility to acute *T. gondii* infection ([@b148-co-2-837]; [@b20-co-2-837]; [@b114-co-2-837]). In contrast, the IL-12-related cytokine, IL-23, which is composed of the shared IL-12 p40 subunit and a unique p19 subunit is not required or essential for mouse immunity to *T. gondii* infection ([@b80-co-2-837]). Thus, IL-12 p40 production by DC and via a MyD88-dependent recognition mechanism is critical and perhaps sufficient for initiating IFN-γ-mediated immunity to *T. gondii* ([@b105-co-2-837]; [@b110-co-2-837]). Related cytokines such as IL-18 and IL-23 may instead play a pathogenic role ([@b97-co-2-837]; [@b45-co-2-837]).

Studies of differential production of IL-12 in BALB/c and DBA/2 mice suggest that strain-specific variation not encoded by MHC genes affects IL-12 production with a skewing of antigen-specific recall responses to either a Th1 or a Th2 direction ([@b53-co-2-837]). In humans, deletions of IL-12 p40 or IL-12 receptors lead to serious impairment of immunity against intracellular bacteria ([@b5-co-2-837]; [@b28-co-2-837]). A complete genomic sequence analysis of the *IL-12* gene encoding its p40 subunit (*IL-12B*) identified several intronic polymorphisms, a single-nucleotide polymorphism (SNP) at position +16974 (+16974 A/C) in the 3′-untranslated region (UTR) of *IL-12B* ([@b58-co-2-837]; [@b68-co-2-837]) and a promoter polymorphism (IL-12Bpro) ([@b96-co-2-837]).

Association between genotype (+16974 A/C) and IL-12p40 production by stimulated PBMC was observed and depend on the stimuli used. There is a significantly decreased IL-12 p40 secretion for the following order of genotypes: AA \> CA \> CC, after stimulation of PBMC with C3-binding glycoprotein (C3bgp) in contrast to lipopolysaccharide, phytohaemagglutinin and pokeweed mitogen ([@b123-co-2-837]). Furthermore, polymorphisms in the *IL12B* 3′UTR gene have been show to influence the secretion of IL-12 and susceptibility to Type 1 diabetes ([@b144-co-2-837]), and the promoter polymorphism may influence the outcome of malaria infection in at least one African population ([@b96-co-2-837]).

CCR5
----

Although low-level IFN-γ production occurs in the absence of IL-12 signaling, optimal induction is strictly IL-12-dependent ([@b20-co-2-837]). Therefore, much effort has been dedicated to disclose the mechanism(s) by which *T. gondii* tachyzoites elicit the production of IL-12 during the initial stages of infection.

The best defined mechanism by which *T. gondii* induces the production of IL-12 is through the parasite-derived cyclophilin-18, which signals murine DCs to produce IL-12 via the chemokine receptor CCR5 ([@b3-co-2-837]; [@b4-co-2-837]). The biological relevance of the unusual requirement for a chemokine receptor to participate in microbial recognition by DCs is supported by the observation that IL-12 production is decreased during acute infections of CCR5-KO animals ([@b3-co-2-837]), although defects in cell migration could also contribute to this susceptible phenotype. In theory, cell-surface CCR5 on DCs could deliver signals derived from stimulation with autologous chemokines that have been induced following microbial stimulation or could be directly triggered by pathogen derived ligands.

In humans, a mutant allele of the CCR5 gene, bearing a 32-bp deletion, results in reduced CCR5 cell surface expression ([@b9-co-2-837]). However, we couldn't observe association between the allele CCR5Δ32 and ocular toxoplasmosis in Brazilian patients (unpublished observations). Incidentally, we and others have found this variant to be quite rare in Brazilian population samples (unpublished results).

The IL-12 levels observed after stimulation of murine DCs with C-18 are much lower than those seen after stimulation with whole-parasite lysate or with a pool of tachyzoite-secreted proteins, indicating that pathways other than those initiated by CCR5 and C-18 might also be important for IL-12 production by DCs ([@b4-co-2-837]).

Conclusion
==========

While the data summarized in this review demonstrate that the binomial IL-12 and IFN-γ production is critical to resistance to *T. gondii* infection in mice, and that an intricate mechanism involving simultaneous activation of different signaling pathways could be required for induction and control of IL-12 during acute infection with *T. gondii*, much remains to be learned about the mechanisms involved and their relevance to parasite and host interactions during natural infection in humans. We had discussed the importance of the genetic background of both the parasite and the host in the establishment of ocular disease and the major questions concerning the specific receptors and parasite ligands required for innate immunity response triggering and how these interactions result in resistance to *T. gondii*.
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